Bewel 150/Bewel 300 Dosage & Drug Information

Concise Prescribing Info

Contents

Irbesartan

Indications/Uses

Essential HTN; renal disease, both early & late stage, in patients w/ HTN & type 2 DM as part of an antihypertensive drug regimen.

Dosage/Direction for Use

Initially 150 mg once daily. May be increased to 300 mg or other antihypertensives may be added.

Administration

May be taken with or without food.

Contraindications

Pregnancy & lactation.

Special Precautions

Vol- & Na-depleted patients by vigorous diuretic therapy, dietary salt restriction, diarrhoea or vomiting. Renovascular HTN, renal impairment & kidney transplantation, aortic or mitral stenosis or obstructive hypertrophic cardiomyopathy. Primary aldosteronism, hypertensive patients w/ type 2 diabetes & renal disease, hyperkalemia. May impair ability to drive or operate machinery.

Adverse Reactions

Dizziness, fatigue, headache, flushing, musculoskeletal trauma, nausea/vomiting, abnormal urination.

View ADR Monitoring Form

Drug Interactions

Diuretics & other antihypertensive agents, K supplements & K-sparing diuretics, lithium, NSAIDs.

MIMS Class

Angiotensin II Antagonists

ATC Classification

C09CA04 - irbesartan ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.

Thai FDA Category

Presentation/Packing

Form

Bewel 150 FC tab 150 mg

Packing/Price

2 × 14's

Form

Bewel 300 FC tab 300 mg

Packing/Price

2 × 14's

Bewel 150/Bewel 300

irbesartan

Manufacturer:

Sriprasit Pharma

Distributor:

SPS Medical

Marketer:

SPS Medical